UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users?

Leal, P; Stein, K; Rosenberg, W; (1999) What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users? J Med Screen , 6 (3) 124 - 131.

Full text not available from this repository.

Abstract

To model the likely cost utility of the prevalence round of a screening programme for hepatitis C (HCV) in intravenous drug users (IVDUs) in contact with services in the South and West health region of the UK.

Type:Article
Title:What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users?
Location:ENGLAND
Language:English
Keywords:Comorbidity, Cost-Benefit Analysis, Enzyme-Linked Immunosorbent Assay, Hepacivirus, Hepatitis C, Humans, Interferon-alpha, Mass Screening, Polymerase Chain Reaction, Prevalence, Sensitivity and Specificity, Substance Abuse, Intravenous

Archive Staff Only: edit this record